 | • レポートコード：MRC23Q35863 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の細胞培養プロセス開発市場について調査・分析し、世界の細胞培養プロセス開発市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（上流工程開発、下流工程開発）、用途別セグメント分析（バイオ医薬品、臨床、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、WuXi Biologics、Pall Corporation、Profacgen、Cytiva、Samsung Biologics、GlobalSpec、FyoniBio、RoosterBio、D&K Engineering, Inc.、Dalton Pharma Services、Ingenero、Avid Bioservices、Richter-Helm、Merck Millipore、Vichem Chemie、EV Groupなどが含まれています。 世界の細胞培養プロセス開発市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、細胞培養プロセス開発市場規模を推定する際に考慮しました。本レポートは、細胞培養プロセス開発の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、細胞培養プロセス開発に関するビジネス上の意思決定に役立てることを目的としています。 ・細胞培養プロセス開発市場の概要 - 細胞培養プロセス開発のタイプ別セグメント - 世界の細胞培養プロセス開発市場規模：タイプ別分析（上流工程開発、下流工程開発） - 細胞培養プロセス開発の用途別セグメント - 世界の細胞培養プロセス開発市場規模：用途別分析（バイオ医薬品、臨床、その他） - 世界の細胞培養プロセス開発市場規模予測（2018年-2029年） ・細胞培養プロセス開発市場の成長トレンド - 細胞培養プロセス開発の地域別市場規模（2018年-2029年） - 細胞培養プロセス開発市場ダイナミクス - 細胞培養プロセス開発の業界動向 - 細胞培養プロセス開発市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：上流工程開発、下流工程開発 - 世界の細胞培養プロセス開発のタイプ別市場規模（2018年-2023年） - 世界の細胞培養プロセス開発のタイプ別市場規模（2024年-2029年） ・用途別セグメント：バイオ医薬品、臨床、その他 - 世界の細胞培養プロセス開発の用途別市場規模（2018年-2023年） - 世界の細胞培養プロセス開発の用途別市場規模（2024年-2029年） ・細胞培養プロセス開発の地域別市場規模 - 北米の細胞培養プロセス開発市場規模（2018年-2029年） - アメリカの細胞培養プロセス開発市場規模（2018年-2029年） - ヨーロッパの細胞培養プロセス開発市場規模（2018年-2029年） - アジア太平洋の細胞培養プロセス開発市場規模（2018年-2029年） - 中国の細胞培養プロセス開発市場規模（2018年-2029年） - 日本の細胞培養プロセス開発市場規模（2018年-2029年） - 韓国の細胞培養プロセス開発市場規模（2018年-2029年） - インドの細胞培養プロセス開発市場規模（2018年-2029年） - オーストラリアの細胞培養プロセス開発市場規模（2018年-2029年） - 中南米の細胞培養プロセス開発市場規模（2018年-2029年） - 中東・アフリカの細胞培養プロセス開発市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 WuXi Biologics、Pall Corporation、Profacgen、Cytiva、Samsung Biologics、GlobalSpec、FyoniBio、RoosterBio、D&K Engineering, Inc.、Dalton Pharma Services、Ingenero、Avid Bioservices、Richter-Helm、Merck Millipore、Vichem Chemie、EV Group ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Cell Culture Process Development market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cell Culture Process Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cell Culture Process Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cell Culture Process Development in Biopharmaceutical is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cell Culture Process Development include WuXi Biologics, Pall Corporation, Profacgen, Cytiva, Samsung Biologics, GlobalSpec, FyoniBio, RoosterBio and D&K Engineering, Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell Culture Process Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Culture Process Development.
The Cell Culture Process Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Culture Process Development market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Culture Process Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
WuXi Biologics
Pall Corporation
Profacgen
Cytiva
Samsung Biologics
GlobalSpec
FyoniBio
RoosterBio
D&K Engineering, Inc.
Dalton Pharma Services
Ingenero
Avid Bioservices
Richter-Helm
Merck Millipore
Vichem Chemie
EV Group
Segment by Type
Upstream Process Development
Downstream Process Development
Segment by Application
Biopharmaceutical
Clinical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Culture Process Development companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Culture Process Development Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Upstream Process Development
1.2.3 Downstream Process Development
1.3 Market by Application
1.3.1 Global Cell Culture Process Development Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceutical
1.3.3 Clinical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Culture Process Development Market Perspective (2018-2029)
2.2 Cell Culture Process Development Growth Trends by Region
2.2.1 Global Cell Culture Process Development Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Culture Process Development Historic Market Size by Region (2018-2023)
2.2.3 Cell Culture Process Development Forecasted Market Size by Region (2024-2029)
2.3 Cell Culture Process Development Market Dynamics
2.3.1 Cell Culture Process Development Industry Trends
2.3.2 Cell Culture Process Development Market Drivers
2.3.3 Cell Culture Process Development Market Challenges
2.3.4 Cell Culture Process Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Culture Process Development Players by Revenue
3.1.1 Global Top Cell Culture Process Development Players by Revenue (2018-2023)
3.1.2 Global Cell Culture Process Development Revenue Market Share by Players (2018-2023)
3.2 Global Cell Culture Process Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Culture Process Development Revenue
3.4 Global Cell Culture Process Development Market Concentration Ratio
3.4.1 Global Cell Culture Process Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Culture Process Development Revenue in 2022
3.5 Cell Culture Process Development Key Players Head office and Area Served
3.6 Key Players Cell Culture Process Development Product Solution and Service
3.7 Date of Enter into Cell Culture Process Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Culture Process Development Breakdown Data by Type
4.1 Global Cell Culture Process Development Historic Market Size by Type (2018-2023)
4.2 Global Cell Culture Process Development Forecasted Market Size by Type (2024-2029)
5 Cell Culture Process Development Breakdown Data by Application
5.1 Global Cell Culture Process Development Historic Market Size by Application (2018-2023)
5.2 Global Cell Culture Process Development Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Culture Process Development Market Size (2018-2029)
6.2 North America Cell Culture Process Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Culture Process Development Market Size by Country (2018-2023)
6.4 North America Cell Culture Process Development Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Culture Process Development Market Size (2018-2029)
7.2 Europe Cell Culture Process Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Culture Process Development Market Size by Country (2018-2023)
7.4 Europe Cell Culture Process Development Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Culture Process Development Market Size (2018-2029)
8.2 Asia-Pacific Cell Culture Process Development Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Culture Process Development Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Culture Process Development Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Culture Process Development Market Size (2018-2029)
9.2 Latin America Cell Culture Process Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Culture Process Development Market Size by Country (2018-2023)
9.4 Latin America Cell Culture Process Development Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Culture Process Development Market Size (2018-2029)
10.2 Middle East & Africa Cell Culture Process Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Culture Process Development Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Culture Process Development Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi Biologics
11.1.1 WuXi Biologics Company Detail
11.1.2 WuXi Biologics Business Overview
11.1.3 WuXi Biologics Cell Culture Process Development Introduction
11.1.4 WuXi Biologics Revenue in Cell Culture Process Development Business (2018-2023)
11.1.5 WuXi Biologics Recent Development
11.2 Pall Corporation
11.2.1 Pall Corporation Company Detail
11.2.2 Pall Corporation Business Overview
11.2.3 Pall Corporation Cell Culture Process Development Introduction
11.2.4 Pall Corporation Revenue in Cell Culture Process Development Business (2018-2023)
11.2.5 Pall Corporation Recent Development
11.3 Profacgen
11.3.1 Profacgen Company Detail
11.3.2 Profacgen Business Overview
11.3.3 Profacgen Cell Culture Process Development Introduction
11.3.4 Profacgen Revenue in Cell Culture Process Development Business (2018-2023)
11.3.5 Profacgen Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Detail
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Cell Culture Process Development Introduction
11.4.4 Cytiva Revenue in Cell Culture Process Development Business (2018-2023)
11.4.5 Cytiva Recent Development
11.5 Samsung Biologics
11.5.1 Samsung Biologics Company Detail
11.5.2 Samsung Biologics Business Overview
11.5.3 Samsung Biologics Cell Culture Process Development Introduction
11.5.4 Samsung Biologics Revenue in Cell Culture Process Development Business (2018-2023)
11.5.5 Samsung Biologics Recent Development
11.6 GlobalSpec
11.6.1 GlobalSpec Company Detail
11.6.2 GlobalSpec Business Overview
11.6.3 GlobalSpec Cell Culture Process Development Introduction
11.6.4 GlobalSpec Revenue in Cell Culture Process Development Business (2018-2023)
11.6.5 GlobalSpec Recent Development
11.7 FyoniBio
11.7.1 FyoniBio Company Detail
11.7.2 FyoniBio Business Overview
11.7.3 FyoniBio Cell Culture Process Development Introduction
11.7.4 FyoniBio Revenue in Cell Culture Process Development Business (2018-2023)
11.7.5 FyoniBio Recent Development
11.8 RoosterBio
11.8.1 RoosterBio Company Detail
11.8.2 RoosterBio Business Overview
11.8.3 RoosterBio Cell Culture Process Development Introduction
11.8.4 RoosterBio Revenue in Cell Culture Process Development Business (2018-2023)
11.8.5 RoosterBio Recent Development
11.9 D&K Engineering, Inc.
11.9.1 D&K Engineering, Inc. Company Detail
11.9.2 D&K Engineering, Inc. Business Overview
11.9.3 D&K Engineering, Inc. Cell Culture Process Development Introduction
11.9.4 D&K Engineering, Inc. Revenue in Cell Culture Process Development Business (2018-2023)
11.9.5 D&K Engineering, Inc. Recent Development
11.10 Dalton Pharma Services
11.10.1 Dalton Pharma Services Company Detail
11.10.2 Dalton Pharma Services Business Overview
11.10.3 Dalton Pharma Services Cell Culture Process Development Introduction
11.10.4 Dalton Pharma Services Revenue in Cell Culture Process Development Business (2018-2023)
11.10.5 Dalton Pharma Services Recent Development
11.11 Ingenero
11.11.1 Ingenero Company Detail
11.11.2 Ingenero Business Overview
11.11.3 Ingenero Cell Culture Process Development Introduction
11.11.4 Ingenero Revenue in Cell Culture Process Development Business (2018-2023)
11.11.5 Ingenero Recent Development
11.12 Avid Bioservices
11.12.1 Avid Bioservices Company Detail
11.12.2 Avid Bioservices Business Overview
11.12.3 Avid Bioservices Cell Culture Process Development Introduction
11.12.4 Avid Bioservices Revenue in Cell Culture Process Development Business (2018-2023)
11.12.5 Avid Bioservices Recent Development
11.13 Richter-Helm
11.13.1 Richter-Helm Company Detail
11.13.2 Richter-Helm Business Overview
11.13.3 Richter-Helm Cell Culture Process Development Introduction
11.13.4 Richter-Helm Revenue in Cell Culture Process Development Business (2018-2023)
11.13.5 Richter-Helm Recent Development
11.14 Merck Millipore
11.14.1 Merck Millipore Company Detail
11.14.2 Merck Millipore Business Overview
11.14.3 Merck Millipore Cell Culture Process Development Introduction
11.14.4 Merck Millipore Revenue in Cell Culture Process Development Business (2018-2023)
11.14.5 Merck Millipore Recent Development
11.15 Vichem Chemie
11.15.1 Vichem Chemie Company Detail
11.15.2 Vichem Chemie Business Overview
11.15.3 Vichem Chemie Cell Culture Process Development Introduction
11.15.4 Vichem Chemie Revenue in Cell Culture Process Development Business (2018-2023)
11.15.5 Vichem Chemie Recent Development
11.16 EV Group
11.16.1 EV Group Company Detail
11.16.2 EV Group Business Overview
11.16.3 EV Group Cell Culture Process Development Introduction
11.16.4 EV Group Revenue in Cell Culture Process Development Business (2018-2023)
11.16.5 EV Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details